[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_6554 

# __Continued evolution and mutation of influenza viruses__

## Articles mentionning the risk

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)

## Mitigations of this risk

* [Research and development of broad-spectrum antiviral drugs, improved surveillance and monitoring](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_8428.md)

## Name of the risk

Health threats from new strains, potential for pandemics

## People affected by this risk

* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)
* [Public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_173.md)

## Stakeholders who can mitigate this risk

* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Advanced genetic sequencing and analysis](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_7961.md)
* [Antiviral drug development](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_7962.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Failure to implement preventive measures](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_12.md)

